Globus Medical (NYSE: GMED) reported Q2 EPS of $0.44, $0.09 better than the analyst estimate of $0.35. Revenue for the quarter came in at $173.4 million versus the consensus estimate of $168.03 million.

GUIDANCE:

Globus Medical sees FY2018 EPS of $1.55, versus the consensus of $1.52. Globus Medical sees FY2018 revenue of $700 million, versus the consensus of $696.16 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.